Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 1 February 1985:
Vol. 227. no. 4686, pp. 548 - 549
DOI: 10.1126/science.3966163
Prev | Table of Contents

Articles

Science, Vol 227, Issue 4686, 548-549
Copyright © 1985 by American Association for the Advancement of Science

articles

Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure

JE Huff, RL Melnick, HA Solleveld, JK Haseman, M Powers, and RA Miller

Groups of 50 male and 50 female B6C3F1 mice were exposed 6 hours per day, 5 days per week, for 60 to 61 weeks to air containing 0, 625, or 1250 parts per million 1,3-butadiene. These concentrations are somewhat below and slightly above the Occupational Safety and Health Administration standard of 1000 parts per million for butadiene. The study was designed for 104-week exposures but had to be ended early due to cancer-related mortality in both sexes at both exposure concentrations. There were early induction and significantly increased incidences of hemangiosarcomas of the heart, malignant lymphomas, alveolar-bronchiolar neoplasms, squamous cell neoplasms of the forestomach in males and females and acinar cell carcinomas of the mammary gland, granulosa cell neoplasms of the ovary, and hepatocellular neoplasms in females. Current workplace standards for exposure to butadiene should be reexamined in view of these findings.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer.
M. J. Hoenerhoff, H. H. Hong, T.-v. Ton, S. A. Lahousse, and R. C. Sills (2009)
Toxicol Pathol 37, 835-848
   Abstract »    Full Text »    PDF »
Clinical evaluation of 1,3-butadiene neurotoxicity in humans.
M. Khalil, M. Abudiab, and A. E. Ahmed (2007)
Toxicology and Industrial Health 23, 141-146
   Abstract »    PDF »
Ratios of N-(2,3,4-trihydroxybutyl) valine and N-(2-hydroxy-3-butenyl) valine formed hemoglobin adducts in female mice inhalation exposure with 1,3-butadiene.
J. H. Lee, H. S. Kang, and D.-H. Han (2005)
Toxicology and Industrial Health 21, 15-20
   Abstract »    PDF »
Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
M.W. Powley, Y. Li, P.B. Upton, V.E. Walker, and J.A. Swenberg (2005)
Carcinogenesis 26, 1573-1580
   Abstract »    Full Text »    PDF »
A Daubert Motion: A Legal Strategy to Exclude Essential Scientific Evidence in Toxic Tort Litigation.
R. L. Melnick (2005)
Am J Public Health 95, S30-S34
   Abstract »    Full Text »    PDF »
Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.
E. Kleymenova, J. I. Everitt, L. Pluta, M. Portis, J. R. Gnarra, and C. L. Walker (2004)
Carcinogenesis 25, 309-315
   Abstract »    Full Text »    PDF »
Carcinogencity Bioassays of Bisphenol A, 4-Vinylcyclohexene Diepoxide, and 4-Vinycyclohexene.
J. Huff (2001)
Toxicol. Sci. 64, 282-283
   Full Text »    PDF »
Mutations of ras Protooncogenes and p53 Tumor Suppressor Gene in Cardiac Hemangiosarcomas from B6C3F1 Mice Exposed to 1,3-Butadiene for 2 Years.
H.-H. L. Hong, T. R. Devereux, R. L. Melnick, C. R. Moomaw, G. A. Boorman, and R. C. Sills (2000)
Toxicol Pathol 28, 529-534
   Abstract »    PDF »
Evaluation of micronuclei and chromosomal breakage in the 1cen-q12 region by the butadiene metabolites epoxybutene and diepoxybutane in cultured human lymphocytes.
M.n. Murg, M. Schuler, and D.A. Eastmond (1999)
Mutagenesis 14, 541-546
   Abstract »    Full Text »    PDF »
Identification of Urinary Metabolites of Isoprene in Rats and Comparison with Mouse Urinary Metabolites.
L. A. Buckley, D. P. Coleman, J. P. Burgess, B. F. Thomas, L. T. Burka, and A. R. Jeffcoat (1999)
Drug Metab. Dispos. 27, 848-854
   Abstract »    Full Text »
Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose–response with 1,3-butadiene in mice.
R. L. Melnick, R. C. Sills, C. J. Portier, J. H. Roycroft, B. J. Chou, S. L. Grumbein, and R. A. Miller (1999)
Carcinogenesis 20, 867-878
   Abstract »    Full Text »    PDF »
Metabolism of 3-Butene-1,2-diol in B6C3F1 Mice. Evidence for Involvement of Alcohol Dehydrogenase and Cytochrome P450.
R. A. Kemper, A. A. Elfarra, and S. R. Myers (1998)
Drug Metab. Dispos. 26, 914-920
   Abstract »    Full Text »
Dangerous and Cancer-Causing Properties of Products and Chemicals in the Oil Refining and Petrochemical Industry - Part II: Carcinogenicity, Mutagenicity, and Developmental Toxicity of 1,3-Butadiene.
M.A. Mehlman and M.S. Legator (1991)
Toxicology and Industrial Health 7, 207-222
   Abstract »    PDF »
Carcinogens and human health: Part 2.
D. Rall (1991)
Science 251, 10-13
   PDF »
Primary Cardiac Hemangiosarcomas Induced by 1,3-Butadiene in B6C3F1 Hybrid Mice.
H. A. Solleveld, R. A. Miller, D. A. Banas, and G. A. Boorman (1988)
Toxicol Pathol 16, 46-52
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)